Emtricitabine/rilpivirine/tenofovir disoproxil Interactions
There are 549 drugs known to interact with emtricitabine/rilpivirine/tenofovir disoproxil, along with 10 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 214 are major, 333 are moderate, and 2 are minor.
- View all 549 medications that may interact with emtricitabine/rilpivirine/tenofovir disoproxil
- View emtricitabine/rilpivirine/tenofovir disoproxil alcohol/food interactions (2)
- View emtricitabine/rilpivirine/tenofovir disoproxil disease interactions (10)
Most frequently checked interactions
View interaction reports for emtricitabine / rilpivirine / tenofovir disoproxil and the medicines listed below.
- Alcohol (contained in alcoholic beverages) (ethanol)
- Dovato (dolutegravir / lamivudine)
- Doxy 100 (doxycycline)
- Rapamune (sirolimus)
- Ritalin (methylphenidate)
Emtricitabine/rilpivirine/tenofovir disoproxil alcohol/food interactions
There are 2 alcohol/food interactions with emtricitabine / rilpivirine / tenofovir disoproxil.
Emtricitabine/rilpivirine/tenofovir disoproxil disease interactions
There are 10 disease interactions with emtricitabine / rilpivirine / tenofovir disoproxil which include:
- hepatitis B
- hepatotoxicity
- hemodialysis
- renal dysfunction
- depression
- liver impairment
- renal impairment
- bone toxicity
- liver disease
- renal dysfunction
More about emtricitabine / rilpivirine / tenofovir disoproxil
- emtricitabine/rilpivirine/tenofovir disoproxil consumer information
- Compare alternatives
- Reviews (60)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antiviral combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.